Fundacion Investigacion y Desarrollo Report issue

Foundation Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00695344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)

Active Ingredients

Drugs in Phase 4 Trials (3)

azathioprine (imuran) (1 trial)

everolimus (zortress) (1 trial)

mycophenolate (CellCept) (1 trial)

Drugs in Phase 2 Trials (1)

wharton's jelly mesenchymal stem cells (1 trial)

Drugs in Phase 1 Trials (1)

autologous dendritic cells loaded with autologous tumor lysate (1 trial)

Drugs in Other Trials (1)

egg (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Cardiovascular Diseases (Phase 2)

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Disease Progression (Phase 4)

Heart Failure (Phase 2)

Myocardial Ischemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6